Edmond de Rothschild (Suisse)’s VanEck Biotech ETF BBH Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$201K	Sell	1,745 -75	-4%	-$8.55K	0.06%	207
2016 Q2	$186K	Buy	1,820 +1,650	+971%	+$176K	0.06%	186
2016 Q1	$18K	Sell	170 -9,650	-98%	-$1.01M	0.01%	319
2015 Q4	$1.25M	Sell	9,820 -2,505	-20%	-$307K	0.47%	47
2015 Q3	$1.41M	Buy	12,325 +5,239	+74%	+$693K	0.48%	51
2015 Q2	$955K	Buy	+7,086	New	+$942K	0.3%	71

Other funds holding BBH

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Timber Hill Greenwich, Connecticut $15.4M AUM 30.7% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.28B AUM 22.9% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s BBH Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) reduced its VanEck Biotech ETF (BBH) stake by 4.1% in Q3 2016, selling an estimated $8.55K and leaving 1,745 shares worth $201K. The position accounts for 0.06% of the portfolio, ranked #207.

Edmond de Rothschild (Suisse) first reported a position in BBH in Q2 2015 and has held it in 6 quarters since. The position peaked at $1.41M in Q3 2015. 80 funds tracked by Wall St. Rank hold BBH as of Q3 2016.

Edmond de Rothschild (Suisse) held 1,745 shares of VanEck Biotech ETF worth $201K as of Q3 2016.
Edmond de Rothschild (Suisse) sold 75 VanEck Biotech ETF shares in Q3 2016, an estimated $8.55K.
VanEck Biotech ETF made up 0.06% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #207 holding.
Edmond de Rothschild (Suisse) first reported a position in VanEck Biotech ETF in Q2 2015 and has held it in 6 quarters since.
Edmond de Rothschild (Suisse)'s VanEck Biotech ETF position peaked at $1.41M in Q3 2015.
80 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.